Adherex Technologies Inc. (NASDAQ:FENC) posted its earnings results on Monday. The company reported ($0.15) EPS for the quarter, RTT News reports. During the same quarter in the prior year, the company earned ($0.04) earnings per share.

Adherex Technologies (NASDAQ:FENC) traded up $0.20 on Tuesday, reaching $10.18. The company’s stock had a trading volume of 5,600 shares, compared to its average volume of 39,021. Adherex Technologies has a 12-month low of $8.00 and a 12-month high of $13.95.

TRADEMARK VIOLATION WARNING: “Adherex Technologies Inc. (FENC) Posts Quarterly Earnings Results” was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at

About Adherex Technologies

Fennec Pharmaceuticals Inc, formerly Adherex Technologies Inc, is a biopharmaceutical company focused on cancer therapeutics. The Company’s lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Receive News & Ratings for Adherex Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adherex Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.